Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
burnett_responds [2019/03/05 02:15] – Carlos Pedrazaburnett_responds [2019/04/15 04:41] (current) – [Copyright Claims] Carlos Pedraza
Line 11: Line 11:
 <WRAP center 90%> <fs smaller>**//See also: [[:peters_sues_burnett|Peters Sues Former Axanar Director in Georgia Court]] and [[:burnett_settlement|Peters Proposes Settling with Former Axanar Director]]//** </fs> </WRAP> <WRAP center 90%> <fs smaller>**//See also: [[:peters_sues_burnett|Peters Sues Former Axanar Director in Georgia Court]] and [[:burnett_settlement|Peters Proposes Settling with Former Axanar Director]]//** </fs> </WRAP>
  
-===== Burnett Not Yet Served =====+===== Burnett Finally Served =====
  
-Almost two weeks have passed since [[:peters_sues_burnett|Peters filed]] his lawsuit in Georgia, and he has still not served Burnett, the former director of //Axanar//, the legal complaint and summons.+<wrap em><fs smaller>UPDATE</fs></wrap> Twenty-five days after [[:peters_sues_burnett|Peters filed]] his lawsuit in Georgia, Burnett, the former director of //Axanar//, was finally served the legal complaint and summons in California on March 15, 2019.
  
  {{page>subscribe}}  {{page>subscribe}}
Line 104: Line 104:
 Peters and Axanar Productions may also have taken and used Burnett’s intellectual property, with the former director and editor never having assigned copyright to Axanar. The attorney says Axanar is "using, marketing and commercially exploiting" Burnett’s copyrighted works. {{:axamonitor-ico.gif?direct&}} Peters and Axanar Productions may also have taken and used Burnett’s intellectual property, with the former director and editor never having assigned copyright to Axanar. The attorney says Axanar is "using, marketing and commercially exploiting" Burnett’s copyrighted works. {{:axamonitor-ico.gif?direct&}}
  
-<WRAP tip 75%> <wrap em>COMMENTS</wrap> Discuss this article in [[face>groups/axamonitor/permalink/590018018179716/|AxaMonitor's Facebook group]]. </WRAP>+<WRAP tip 90%> <wrap em>COMMENT & SHARE</wrap> \\ <wrap lo> Discuss this article in [[face>groups/axamonitor/permalink/590018018179716/|AxaMonitor's Facebook group]] or share on:</wrap> 
 +~~socialite~~</WRAP>
  
 ---- ----